AI assistant
MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2007
Jun 26, 2007
65396_rns_2007-06-26_4e93de9f-1194-48bd-9f27-ec53f0fd0e3e.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

| ASX Circular | CO ΗA |
|---|---|
| Date: 27 June, 2007 | Halcy |
| Key topics 1. HalcyGen Pharmaceuticals |
of AS |
| Emred 2. ASX Code: HGN |
Offic 2007 |
| 3. Quotation commences: 11.00 AM EST, Friday 29 June 2007. |
Quot |
| Reading List Banks |
|
| Client Advisers | |
| Compliance Managers Corporate Advisory |
|
| DTH Operators Issuers |
|
| institutions | |
| ASTC Participants Operations Managers (back |
|
| office) Share Registries |
|
| ACH Participants Market Participants |
|
| Contact | |
| Kate Kidson | |
| Telephone | |
| (03) 9617 7831 | |
| ASX Limited ABN 98 008 624 691 |
|
| Exchange Centre 20 Bridge Street |
|
| Sydney NSW 2000 PO Box H224 Australia Square NSW 1215 |
|
| Internet: http://www.asx.com.au | |
| Divid |
MMENCEMENT OF OFFICIAL QUOTATION -LCYGEN PHARMACEUTICALS LIMITED
yGen Pharmaceuticals Limited (the "Company") was admitted to the official list SX Limited on Wednesday, 27 June 2007.
ial quotation of the Company's securities will commence on Friday, 29 June
ed Securities: 34,421,200 ordinary shares fully paid Code: HGN 11.00 AM EST Ľ, Friday, 29 June 2007 Abbreviation: HalcyGen AU000000HGN8 e Branch: Melbourne TBA stry Classification: stered Office: Level 10 470 Collins Street Melbourne, VIC 3000 Phone:- (03) 8614 7777 Fax:- (03) 9614 7022 pany Secretary: Aaron Finlay Computershare Investor Services Pty e Registry: Ltd Level 2 45 St Georges Terrace Perth WA 6000 Tolhurst Limited nwriter to the issue: 30 June nce Date: SS: Participating. The Company will also operate an issuer sponsored subregister. Western Australia e of Incorporation: restricted securities: See below See page 48 of the prospectus dated 23 lend Policy: May 2007.
Activities:
Securities not quoted:
The testing and improvement of generic drugs.
22,295,000 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a of 24 period months from commencement of official quotation.
3,250,000 options exercisable at 10 cents each on or before 30 June 2010 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.
1,625,000 options exercisable at 60 cents each on or before 17 April 2011 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.
1,375,000 options exercisable at 60 cents each on or before 17 April 2012 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.
17,782,800 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a period of 12 months from the date of issue being 18 September 2006.
1,600,000 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a period of 12 months from the date of issue being 18 February 2007.